Wiley Bros. Aintree Capital, LLC Exact Sciences Corp Transaction History
Wiley Bros. Aintree Capital, LLC
- $12.5 Billion
- Q2 2025
A detailed history of Wiley Bros. Aintree Capital, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Wiley Bros. Aintree Capital, LLC holds 15,472 shares of EXAS stock, worth $877,571. This represents 0.01% of its overall portfolio holdings.
Number of Shares
15,472Holding current value
$877,571% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding EXAS
# of Institutions
651Shares Held
157MCall Options Held
1.43MPut Options Held
2.3M-
Capital World Investors Los Angeles, CA18.2MShares$1.03 Billion0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.9MShares$1.02 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$684 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12MShares$681 Million0.12% of portfolio
-
State Street Corp Boston, MA5.38MShares$305 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...